Kaplan-Meier curves for patients with ER-positive/HER2-negative breast cancer show significant difference in RFS between patients with a radiological complete response and those with residual enhancement on MRI (log-rank p = 0.012; Fig. 3). The gene discussed is ESR1; the disease is breast carcinoma.